Decibel Therapeutics
BioTech/Drugs - Boston, MA, US
Decibel Therapeutics Employees
Yong Ren
G Ren’S Profile On Linkedin, The Worlds Largest Professional Community. ... Associate Director
Steven Holtzman
Tzman’S Profile On Linkedin, The Worlds Largest Professional Community. ... President And Chief Executive Officer
Decibel Therapeutics Senior Management
Steven Holtzman
Tzman’S Profile On Linkedin, The Worlds Largest Professional Community. ... President And Chief Executive Officer
Elisabeth Leiderman
Chief Financial Officer & Head of Corporate Development
Decibel Therapeutics Details
Decibel Therapeutics is a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, one of the largest areas of unmet need in medicine. Decibel has built a proprietary platform that integrates single-cell genomics and bioinformatic analyses, precision gene therapy technologies and expertise in inner ear biology. Decibel is leveraging its platform to advance gene therapies designed to selectively replace genes for the treatment of congenital, monogenic hearing loss and to regenerate inner ear hair cells for the treatment of acquired hearing and balance disorders. Decibel's pipeline, including its lead gene therapy program, DB-OTO, to treat congenital, monogenic hearing loss, is designed to deliver on our vision of building a world of connection for people with hearing and balance disorders.Guidelines: https://bit.ly/3IzmNvU
Decibel Therapeutics Technologies
Email Providers
Outlook
Domain Name Services
Route 53
Support and Feedback
Zendesk
Hosting
Google Cloud Hosting
Search Marketing
Adobe Marketing Cloud